MIST
Milestone Pharmaceuticals Inc

7,201
Mkt Cap
$151.6M
Volume
738,403.00
52W High
$3.06
52W Low
$0.6254
PE Ratio
-2.06
MIST Fundamentals
Price
$1.75
Prev Close
$1.78
Open
$1.77
50D MA
$1.87
Beta
1.36
Avg. Volume
1.77M
EPS (Annual)
-$0.6674
P/B
7.39
Rev/Employee
$0.00
$131.92
Loading...
Loading...
News
all
press releases
Milestone Pharmaceuticals Inc. $MIST Shares Purchased by Propel Bio Management LLC
Propel Bio Management LLC boosted its holdings in shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Free Report) by 186.1% during the 3rd quarter, according to its most recent filing with the...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Receives Average Rating of "Hold" from Brokerages
Shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) have received a consensus recommendation of "Hold" from the six analysts that are presently covering the company, MarketBeat...
MarketBeat·6d ago
News Placeholder
Milestone Pharmaceuticals (MIST) Projected to Post Earnings on Thursday
Milestone Pharmaceuticals (NASDAQ:MIST) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...
MarketBeat·6d ago
News Placeholder
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Short Interest Update
Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) was the target of a significant drop in short interest in February. As of February 13th, there was short interest totaling 7,474,168...
MarketBeat·9d ago
News Placeholder
Zacks Research Downgrades Milestone Pharmaceuticals (NASDAQ:MIST) to Hold
Zacks Research cut Milestone Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a research report on Tuesday...
MarketBeat·13d ago
News Placeholder
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Given Consensus Recommendation of "Moderate Buy" by Analysts
Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six research firms that are covering the company, MarketBeat.com...
MarketBeat·1mo ago
News Placeholder
Milestone Pharmaceuticals (NASDAQ:MIST) Insider Sells $21,577.40 in Stock
Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) insider Lorenz Muller sold 11,180 shares of the company's stock in a transaction dated Monday, January 26th. The stock was sold at an...
MarketBeat·1mo ago
News Placeholder
Milestone Pharmaceuticals (NASDAQ:MIST) Insider David Bharucha Sells 12,245 Shares
Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) insider David Bharucha sold 12,245 shares of the business's stock in a transaction that occurred on Monday, January 26th. The stock was...
MarketBeat·1mo ago
News Placeholder
Insider Selling: Milestone Pharmaceuticals (NASDAQ:MIST) COO Sells 12,245 Shares of Stock
Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) COO Jeffrey Edward Nelson sold 12,245 shares of the company's stock in a transaction that occurred on Monday, January 26th. The stock...
MarketBeat·1mo ago
News Placeholder
Milestone Pharmaceuticals (NASDAQ:MIST) CEO Sells $66,629.39 in Stock
Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) CEO Joseph Oliveto sold 34,523 shares of the stock in a transaction that occurred on Monday, January 26th. The shares were sold at an...
MarketBeat·1mo ago
<
1
2
...
>

Latest MIST News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.